The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Prevoznik Michael E since 2015.
This trader's CIK number is 1222679.
At the time of last reporting, Prevoznik Michael E was the SVP & General Counsel of Quest Diagnostics Inc. (stock ticker symbol DGX).
Also see all insider trading activities at Quest Diagnostics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DGX | 0 | $0 | 34,465 | $6,352,423 | 28,690 | $2,971,422 |
| 2024 | DGX | 0 | $0 | 73,308 | $11,469,197 | 67,697 | $6,162,920 |
| 2023 | DGX | 0 | $0 | 6,762 | $950,437 | 0 | $0 |
| 2022 | DGX | 0 | $0 | 59,162 | $8,221,735 | 50,604 | $3,365,672 |
| 2021 | DGX | 0 | $0 | 52,502 | $7,059,585 | 44,939 | $3,198,308 |
| 2020 | DGX | 0 | $0 | 38,777 | $4,572,954 | 35,591 | $1,856,604 |
| 2019 | DGX | 0 | $0 | 49,677 | $5,234,620 | 44,556 | $2,412,395 |
| 2018 | DGX | 0 | $0 | 36,331 | $4,045,643 | 30,780 | $1,773,081 |
| 2017 | DGX | 0 | $0 | 95,088 | $9,148,961 | 88,500 | $4,842,164 |
| 2016 | DGX | 0 | $0 | 3,815 | $260,965 | 0 | $0 |
| 2015 | DGX | 0 | $0 | 3,749 | $266,890 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-26 | DGX | Option Ex | 227 | 103.57 | 23,510 |
| 2025-09-26 | DGX | Sale | 227 | 187.94 | 42,662 |
| 2025-09-23 | DGX | Option Ex | 28,288 | 103.57 | 2,929,788 |
| 2025-09-24 | DGX | Option Ex | 175 | 103.57 | 18,124 |
| 2025-09-23 | DGX | Sale | 28,288 | 187.12 | 5,293,307 |
| 2025-09-24 | DGX | Sale | 175 | 187.02 | 32,729 |
| 2025-03-17 | DGX | Sale | 4,643 | 170.00 | 789,310 |
| 2025-02-27 | DGX | Sale | 528 | 172.61 | 91,138 |
| 2025-02-20 | DGX | Sale | 604 | 170.99 | 103,277 |
| 2024-11-29 | DGX | Option Ex | 35,146 | 86.63 | 3,044,697 |
| 2024-11-29 | DGX | Sale | 35,146 | 162.70 | 5,718,359 |
| 2024-08-29 | DGX | Sale | 32,551 | 154.97 | 5,044,526 |
| 2024-08-29 | DGX | Option Ex | 32,551 | 95.80 | 3,118,223 |
| 2024-02-29 | DGX | Sale | 5,611 | 125.88 | 706,312 |
| 2023-03-07 | DGX | Sale | 4,754 | 140.55 | 668,174 |
| 2023-03-02 | DGX | Sale | 593 | 138.54 | 82,154 |
| 2023-02-24 | DGX | Sale | 1,415 | 141.42 | 200,109 |
| 2022-05-17 | DGX | Option Ex | 50,604 | 66.51 | 3,365,672 |
| 2022-05-17 | DGX | Sale | 50,604 | 139.97 | 7,082,991 |
| 2022-03-08 | DGX | Sale | 6,228 | 135.21 | 842,087 |
| 2022-02-28 | DGX | Sale | 661 | 130.00 | 85,930 |
| 2022-02-24 | DGX | Sale | 1,669 | 126.26 | 210,727 |
| 2021-05-05 | DGX | Sale | 44,939 | 137.00 | 6,156,643 |
| 2021-05-05 | DGX | Option Ex | 44,939 | 71.17 | 3,198,308 |
| 2021-03-10 | DGX | Sale | 5,574 | 120.47 | 671,499 |
| 2021-02-25 | DGX | Sale | 801 | 115.49 | 92,507 |
| 2021-02-24 | DGX | Sale | 1,188 | 116.95 | 138,936 |
| 2020-10-14 | DGX | Option Ex | 35,591 | 52.16 | 1,856,604 |
| 2020-10-14 | DGX | Sale | 35,591 | 119.00 | 4,235,329 |
| 2020-03-11 | DGX | Sale | 2,175 | 104.25 | 226,743 |
| 2020-02-26 | DGX | Sale | 321 | 111.09 | 35,659 |
| 2020-02-27 | DGX | Sale | 690 | 109.02 | 75,223 |
| 2019-11-27 | DGX | Option Ex | 44,556 | 54.14 | 2,412,395 |
| 2019-11-27 | DGX | Sale | 44,556 | 107.50 | 4,789,814 |
| 2019-03-04 | DGX | Sale | 3,373 | 86.81 | 292,810 |
| 2019-02-27 | DGX | Sale | 1,048 | 86.51 | 90,662 |
| 2019-02-26 | DGX | Sale | 364 | 87.06 | 31,689 |
| 2019-02-25 | DGX | Sale | 336 | 88.23 | 29,645 |
| 2018-07-10 | DGX | Sale | 30,780 | 113.06 | 3,480,140 |
| 2018-07-10 | DGX | Option Ex | 30,780 | 57.60 | 1,773,081 |
| 2018-03-05 | DGX | Sale | 4,128 | 101.00 | 416,928 |
| 2018-02-28 | DGX | Sale | 496 | 104.99 | 52,075 |
| 2018-02-27 | DGX | Sale | 927 | 104.10 | 96,500 |
| 2017-04-20 | DGX | Option Ex | 29,513 | 56.23 | 1,659,663 |
| 2017-04-20 | DGX | Sale | 29,513 | 100.00 | 2,951,300 |
| 2017-03-16 | DGX | Option Ex | 13,987 | 55.65 | 778,376 |
| 2017-03-16 | DGX | Sale | 13,987 | 100.00 | 1,398,700 |
| 2017-03-03 | DGX | Sale | 4,478 | 98.29 | 440,142 |
| 2017-03-01 | DGX | Sale | 470 | 97.77 | 45,951 |
| 2017-02-27 | DGX | Sale | 440 | 97.39 | 42,851 |
| 2017-02-13 | DGX | Sale | 1,200 | 93.76 | 112,512 |
| 2017-02-02 | DGX | Option Ex | 45,000 | 53.42 | 2,404,125 |
| 2017-02-02 | DGX | Sale | 45,000 | 92.39 | 4,157,505 |
| 2016-03-01 | DGX | Sale | 3,815 | 68.41 | 260,965 |
| 2015-03-03 | DGX | Sale | 3,261 | 71.16 | 232,042 |
| 2015-02-17 | DGX | Sale | 488 | 71.41 | 34,848 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Prevoznik Michael E (SVP & General Counsel of Quest Diagnostics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.